ADUS:NGS-Addus HomeCare Corporation

EQUITY | Medical Care | Nasdaq Global Select

Last Closing

USD 76.16

Change

-0.92 (-1.19)%

Market Cap

USD 0.39B

Volume

0.06M

Analyst Target

USD 80.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Addus HomeCare Corp provides home and community based services, which are social in nature and are provided in the home, focused on the dual eligible population.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-07-15 )

Largest Industry Peers for Medical Care

ETFs Containing ADUS

SBM 7.23 % 0.95 %

N/A

N/A
SMN ProShares UltraShort Basi.. 7.23 % 0.95 %

-0.19 (0.34%)

USD 1.07M
ABEQ Absolute Core Strategy ET.. 5.09 % 0.00 %

+0.47 (+0.34%)

USD 0.08B
JHMA 4.37 % 0.47 %

N/A

N/A
5HEE:F Ossiam Irl Icav - Ossiam .. 4.31 % 0.00 %

+0.54 (+0.34%)

N/A
5HEE:XETRA Ossiam ESG Low Carbon Shi.. 4.31 % 0.00 %

+0.48 (+0.34%)

USD 0.47B
5HED:XETRA Ossiam ESG Low Carbon Shi.. 4.31 % 0.00 %

+0.40 (+0.34%)

USD 0.44B
XLPE:LSE Xtrackers LPX Private Equ.. 3.49 % 0.00 %

-48.50 (0.34%)

USD 0.34B
VVAL:LSE 0.54 % 0.00 %

N/A

N/A
SCHJ Schwab 1-5 Year Corporate.. 0.09 % 0.00 %

+0.10 (+0.34%)

USD 0.39B
BIV Vanguard Intermediate-Ter.. 0.05 % 0.07 %

+0.29 (+0.34%)

USD 17.20B
BLV Vanguard Long-Term Bond I.. 0.04 % 0.07 %

+0.66 (+0.34%)

USD 6.22B
BSV Vanguard Short-Term Bond .. 0.02 % 0.07 %

+0.13 (+0.34%)

USD 31.36B
SPVM Invesco S&P 500 Value wit.. 0.00 % 0.39 %

+0.82 (+0.34%)

USD 0.09B
WMCR 0.00 % 0.50 %

N/A

N/A
SCHI Schwab 5-10 Year Corporat.. 0.00 % 0.00 %

+0.23 (+0.34%)

USD 6.31B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.20% 67% D+ 56% F
Dividend Return N/A N/A N/A N/A F
Total Return 12.20% 67% D+ 53% F
Trailing 12 Months  
Capital Gain 27.36% 67% D+ 88% B+
Dividend Return N/A N/A N/A N/A F
Total Return 27.36% 67% D+ 88% B+
Trailing 5 Years  
Capital Gain 251.62% 50% F 94% A
Dividend Return N/A N/A N/A N/A F
Total Return 251.62% 50% F 93% A
Average Annual (5 Year Horizon)  
Capital Gain 37.55% 67% D+ 86% B+
Dividend Return 37.55% 67% D+ 86% B+
Total Return N/A N/A N/A N/A F
Risk Return Profile  
Volatility (Standard Deviation) 42.77% 47% F 33% F
Risk Adjusted Return 87.79% 87% B+ 90% A-
Market Capitalization 0.39B 77% C+ 71% C-

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 49.30 45% 18%
Price/Book Ratio 3.56 31% 33%
Price / Cash Flow Ratio 0.00 15% 19%
Price/Free Cash Flow Ratio 0.00 15% 12%
Management Effectiveness  
Return on Equity 7.51% 55% 61%
Return on Invested Capital N/A N/A N/A
Return on Assets 6.15% 69% 85%
Debt to Equity Ratio 6.25% 58% 81%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.